CompletedPhase 1NCT02286518

TAK-114 Single- and Multiple-Dose Phase 1 Study

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Takeda
Principal Investigator
General Manager
Takeda
Intervention
TAK-114 10 mg capsule(drug)
Enrollment
82 enrolled
Eligibility
20-45 years · MALE
Timeline
20142015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02286518 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials